Answers are grounded in this paper and cite their sources.
"EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database" published on 28 Mar 2025 by National Comprehensive Cancer Network.
No takes yet. Share an insight, caveat, or question.
Tariq et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: